2006 annual financial data
Celldex Therapeutics 2006 Operating cash flow margin
Direct answer
Operating cash flow margin was 547.55%.
Operating income was -22,367,259 USD and net income was -20,373,932 USD.
Operating cash flow was 27,000,319 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,931,097 USD
- Operating income
- -22,367,259 USD
- Net income
- -20,373,932 USD
- Operating cash flow
- 27,000,319 USD